This clearance makes EchoGo ® Amyloidosis ... The two primary precursor proteins that form the predominant subtypes of Cardiac Amyloidosis in the United States of America are transthyretin ...

This clearance makes EchoGo ® Amyloidosis the first commercially ... The two primary precursor proteins that form the predominant subtypes of Cardiac Amyloidosis in the United States of America are ...

HeartSciences' first product candidate for FDA clearance, the MyoVista® wavECG™, or the MyoVista®, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac ...

FORT MILL, SC / ACCESSWIRE / November 14, 2024 / . (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced it has received its first ...

Phase 1a highlights: Safety Results: TX45 was well tolerated with no drug-related severe adverse events, no evidence of immune-mediated clearance, and no antidrug ... of Group 2 PH patients with a ...

The American Heart Association notes that nearly half of all U.S. adults have some form of cardiovascular disease (CVD), and ...

The hypoparathyroidism treatment space has made a buzz in 2024 with a major drug approval, acquisitions, and big advances in ...